Haitian Creole
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
inflammation/fatigue
Lyen an sove nan clipboard la
Paj 1 soti nan 29 rezilta yo
Preventive and/or ameliorative agent for diseases, stamina enhancement agent, anti-fatigue agent, and pharmaceutical and food and drink using them
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present invention relates to a preventive and/or ameliorative agent for diseases, a stamina enhancement agent, and an anti-fatigue agent, a pharmaceutical and a food and drink, using them.
BACKGROUND ART
It is known that the balance in a network of an immune system, a nervous
Antibodies to IL-6 to inhibit or treat inflammation
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
Curcumin compositions and uses thereof
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD
Curcumin compositions herein are described to improve performance and endurance for normal physical and/or sports activities and to reduce the stress on body systems resulting from these activities. The compositions are comprised of curcumin either alone or along with at least one more
Uses of ether phospholipids in treating diseases
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
FIELD OF THE INVENTION
The present invention relates to uses of ether phospholipids in treating and preventing various diseases, including, but not limited to, neurodegenerative or brain diseases; metabolic diseases or syndromes; infectious diseases; diseases related to inflammation; heart diseases,
Enzyme formulation for reducing histamine intolerance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
Enzyme formulation for reducing histamine intolerance
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
BACKGROUND
In the past six years or so, there has been an increase in research about histamine intolerance, which has generated clinical evidence of it, and more internet sites with options to help those who are intolerant. It is believed that many who are intolerant to histamine can have the
Treatment of the acute after-effects resulting from alcohol ingestion
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
This invention relates to the prevention of the acute post-alcoholic intoxication state, commonly called the alcohol "hangover". A "hangover" results from ingesting a relatively excessive quantity of alcohol, a term understood to refer to alcoholic beverages as well as any particular alcohol found
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amine group --NR.sup.1R.sup.2 may form together with two neighboring carbon atoms
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00002## wherein A is phenyl or a five or six membered heteroaryl group, containing one or two N atoms, selected from
##STR00003## or the amide group --C(O)--NR.sup.1R.sup.2 may form together with two
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## or the oxygen atom may form together with two neighboring carbon atoms from the group A
Indolin-2-one derivatives
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
The present invention is concerned with indolin-2-one derivatives of general formula
##STR00004## wherein A is phenyl or a six membered heteroaryl group, containing one or two N atoms, selected from
##STR00005## R.sup.1 is S(O).sub.2lower alkyl, S(O).sub.2NR.sup.4R.sup.5, S(O).sub.2cycloalkyl,
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Composition and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Compositions and methods for treating intestinal hyperpermeability
Se sèlman itilizatè ki anrejistre yo ki ka tradwi atik yo
Log In / Enskri
TECHNICAL FIELD
The present inventions relate generally to compositions, kits, and methods for the treatment of intestinal hyperpermeability.
BACKGROUND
The intestinal epithelium separates luminal contents from the interstitium. This function is primarily determined by the integrity of the
Baz done ki pi konplè remèd fèy medsin te apiye nan syans
- Travay nan 55 lang
- Geri èrbal te apiye nan syans
- Remèd fèy rekonesans pa imaj
- Kat entèaktif GPS - tag zèb sou kote (vini byento)
- Li piblikasyon syantifik ki gen rapò ak rechèch ou an
- Search remèd fèy medsin pa efè yo
- Izeganize enterè ou yo ak rete kanpe fè dat ak rechèch la nouvèl, esè klinik ak rive
Tape yon sentòm oswa yon maladi epi li sou remèd fèy ki ta ka ede, tape yon zèb ak wè maladi ak sentòm li itilize kont.
* Tout enfòmasyon baze sou rechèch syantifik pibliye
